TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 135 filers reported holding TG THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $21,000 | +110.0% | 1,500 | +20.0% | 0.06% | +129.2% |
| Q4 2017 | $10,000 | -72.2% | 1,250 | -58.8% | 0.02% | -62.5% |
| Q3 2017 | $36,000 | +20.0% | 3,032 | 0.0% | 0.06% | +33.3% |
| Q2 2017 | $30,000 | -80.5% | 3,032 | -77.1% | 0.05% | -78.2% |
| Q1 2017 | $154,000 | +185.2% | 13,248 | +278.5% | 0.22% | +238.5% |
| Q1 2015 | $54,000 | -19.4% | 3,500 | -17.6% | 0.06% | -16.7% |
| Q4 2014 | $67,000 | +26.4% | 4,250 | -15.0% | 0.08% | +14.7% |
| Q3 2014 | $53,000 | +2550.0% | 5,000 | +1900.0% | 0.07% | +2166.7% |
| Q2 2014 | $2,000 | -50.0% | 250 | -50.0% | 0.00% | -57.1% |
| Q1 2014 | $4,000 | 0.0% | 500 | -50.0% | 0.01% | +16.7% |
| Q4 2013 | $4,000 | – | 1,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 6,880,323 | $38,633,000 | 2.30% |
| Eversept Partners, LP | 773,501 | $4,343,208 | 1.35% |
| Opaleye Management Inc. | 612,500 | $3,439,000 | 1.24% |
| BRIDGER MANAGEMENT, LLC | 2,334,196 | $13,107,000 | 1.08% |
| Sofinnova Investments, Inc. | 1,733,628 | $9,734,000 | 0.88% |
| PURA VIDA INVESTMENTS, LLC | 354,719 | $1,992,000 | 0.34% |
| 683 Capital Management, LLC | 400,000 | $2,246,000 | 0.25% |
| NEXPOINT ASSET MANAGEMENT, L.P. | 649,460 | $3,646,000 | 0.23% |
| Artal Group S.A. | 900,000 | $5,054,000 | 0.20% |
| Frontier Wealth Management LLC | 226,750 | $1,273,000 | 0.19% |